Company Profile

SensiQ Technologies Inc
Profile last edited on: 6/15/21      CAGE: 5M1Y9      UEI:

Business Identifier: Biomolecular Interaction Analysis, Surface Plasmon Resonance, Fragment Screening, Assay Development
Year Founded
2003
First Award
2013
Latest Award
2014
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

800 Research Parkway Suite 100
Oklahoma City, OK 73104
   (405) 239-8600
   matthew.cumming@sensiqtech.com
   www.sensiqtech.com
Location: Single
Congr. District: 05
County: Oklahoma

Public Profile

SensiQ Technologies, Inc. develops and manufactures tools for the life sciences research market. It offers a suite of instruments and platforms for biomolecular interaction analysis applications. The company also provides SensíQ Pioneer, which performs characterization of biomolecular interactions, including antibody selection and screening, drug discovery, ligand fishing, binding specificity, and gene regulation; and SensíQ Pioneer ST, a three-channel automated surface Plasmon resonance system for academic researchers to perform binding interaction analyses. In addition, it offers SensíQ, a surface Plasmon resonance system for biomolecular interaction analysis; SensíQ Discovery, a manual and dual-channel instrument for university researchers, instructors, and teaching laboratories to perform analysis applications that include binding specificity, kinetics, affinity, concentration assays, and binding stoichiometry; and surface chemistries. Further, the company provides technical support, training, surface Plasmon resonance, and custom assay and surface chemistry development servic

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $1,397,557
Project Title: Label-Free Platform for Applications in Drug Discovery

Key People / Management

  Colin J Cumming -- President

  Jim Luby -- President

  Matthew Cumming -- Office Manager

  David Wesley Goad

  Tom Jobe -- COO